All changes for the tissue urinary system (67)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA258
EF-hand domain family, member D1
Molecular
kidney
Human
EFHD1
9.0% Decrease Gene Expression Level
DAA271
epidermal growth factor (beta-urogastrone)
Molecular
kidney
Human
EGF
25.0% Decrease Gene Expression Level
DAA280
FXYD domain containing ion transport regulator 2
Molecular
kidney
Human
FXYD2
5.0% Decrease Gene Expression Level
DAA262
kelch-like 3 (Drosophila)
Molecular
kidney
Human
KLHL3
14.0% Decrease Gene Expression Level
DAA289
brain protein 44-like
Molecular
kidney
Human
BRP44L
9.0% Decrease Gene Expression Level
DAA291
chromosome 1 open reading frame 162
Molecular
kidney
Human
C1orf162
37.0% Increase Gene Expression Level
DAA285
immunoglobulin kappa variable 1-5
Molecular
kidney
Human
IGKV1-5
35.0% Increase Gene Expression Level
DAA274
immunoglobulin lambda variable 3-25
Molecular
kidney
Human
IGLV3-25
46.0% Increase Gene Expression Level
DAA284
immunoglobulin lambda variable 4-3
Molecular
kidney
Human
IGLV4-3
41.0% Increase Gene Expression Level
DAA261
hypothetical LOC100126583
Molecular
kidney
Human
—
43.0% Increase Gene Expression Level
DAA260
hypothetical protein LOC284214
Molecular
kidney
Human
—
53.0% Increase Gene Expression Level
DAA890
IgM deposition in glomeruli
Molecular
glomerulus
Human
—
—
DAA259
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
Molecular
kidney
Human
IGJ
60.0% Increase Gene Expression Level
DAA263
claudin 8
Molecular
kidney
Human
CLDN8
17.0% Decrease Gene Expression Level
DAA886
Renal arteriosclerosis
Pathological
renal vasculature
Human
—
—
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA640
Renal failure
Pathological
kidney
Human
—
SeriesMorbidity
DAA620
Hypertensive heart and renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA604
Cancer of kidney and renal pelvis
Pathological
urinary system
Human
—
SeriesMorbidity
DAA639
Kidney diseases
Pathological
kidney
Human
—
SeriesMorbidity
DAA605
Bladder cancer
Pathological
bladder
Human
—
SeriesMorbidity
DAA884
Widespread degeneration of glomerular blood vessels
Physiological
renal vasculature
Human
—
—
DAA895
Basement membranes of glomeruli and tubules thicken
Physiological
renal tubule, glomerulus
Human
—
—
DAA895
Basement membranes of glomeruli and tubules thicken
Physiological
renal tubule, glomerulus
Human
—
—
DAA1062
Creatinine clearance declines
Physiological
kidney
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA258 | EF-hand domain family, member D1 | Molecular | kidney | Human | EFHD1 | 9.0% Decrease Gene Expression Level | |
DAA271 | epidermal growth factor (beta-urogastrone) | Molecular | kidney | Human | EGF | 25.0% Decrease Gene Expression Level | |
DAA280 | FXYD domain containing ion transport regulator 2 | Molecular | kidney | Human | FXYD2 | 5.0% Decrease Gene Expression Level | |
DAA262 | kelch-like 3 (Drosophila) | Molecular | kidney | Human | KLHL3 | 14.0% Decrease Gene Expression Level | |
DAA289 | brain protein 44-like | Molecular | kidney | Human | BRP44L | 9.0% Decrease Gene Expression Level | |
DAA291 | chromosome 1 open reading frame 162 | Molecular | kidney | Human | C1orf162 | 37.0% Increase Gene Expression Level | |
DAA285 | immunoglobulin kappa variable 1-5 | Molecular | kidney | Human | IGKV1-5 | 35.0% Increase Gene Expression Level | |
DAA274 | immunoglobulin lambda variable 3-25 | Molecular | kidney | Human | IGLV3-25 | 46.0% Increase Gene Expression Level | |
DAA284 | immunoglobulin lambda variable 4-3 | Molecular | kidney | Human | IGLV4-3 | 41.0% Increase Gene Expression Level | |
DAA261 | hypothetical LOC100126583 | Molecular | kidney | Human | — | 43.0% Increase Gene Expression Level | |
DAA260 | hypothetical protein LOC284214 | Molecular | kidney | Human | — | 53.0% Increase Gene Expression Level | |
DAA890 | IgM deposition in glomeruli | Molecular | glomerulus | Human | — | — | |
DAA259 | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | Molecular | kidney | Human | IGJ | 60.0% Increase Gene Expression Level | |
DAA263 | claudin 8 | Molecular | kidney | Human | CLDN8 | 17.0% Decrease Gene Expression Level | |
DAA886 | Renal arteriosclerosis | Pathological | renal vasculature | Human | — | — | |
DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA640 | Renal failure | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA620 | Hypertensive heart and renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA604 | Cancer of kidney and renal pelvis | Pathological | urinary system | Human | — | SeriesMorbidity | |
DAA639 | Kidney diseases | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA605 | Bladder cancer | Pathological | bladder | Human | — | SeriesMorbidity | |
DAA884 | Widespread degeneration of glomerular blood vessels | Physiological | renal vasculature | Human | — | — | |
DAA895 | Basement membranes of glomeruli and tubules thicken | Physiological | renal tubule, glomerulus | Human | — | — | |
DAA895 | Basement membranes of glomeruli and tubules thicken | Physiological | renal tubule, glomerulus | Human | — | — | |
DAA1062 | Creatinine clearance declines | Physiological | kidney | Human | — | — |